132 related articles for article (PubMed ID: 30269599)
21. Possible leap ahead in filovirus therapeutics.
Falzarano D; Feldmann H
Cell Res; 2014 Jun; 24(6):647-8. PubMed ID: 24732011
[TBL] [Abstract][Full Text] [Related]
22. Role of EXT1 and Glycosaminoglycans in the Early Stage of Filovirus Entry.
O'Hearn A; Wang M; Cheng H; Lear-Rooney CM; Koning K; Rumschlag-Booms E; Varhegyi E; Olinger G; Rong L
J Virol; 2015 May; 89(10):5441-9. PubMed ID: 25741008
[TBL] [Abstract][Full Text] [Related]
23. Animal models used to assess influenza antivirals.
Mifsud EJ; Tai CM; Hurt AC
Expert Opin Drug Discov; 2018 Dec; 13(12):1131-1139. PubMed ID: 30362841
[TBL] [Abstract][Full Text] [Related]
24. Potential vaccines and post-exposure treatments for filovirus infections.
Friedrich BM; Trefry JC; Biggins JE; Hensley LE; Honko AN; Smith DR; Olinger GG
Viruses; 2012 Sep; 4(9):1619-50. PubMed ID: 23170176
[TBL] [Abstract][Full Text] [Related]
25. Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections.
Swenson DL; Warfield KL; Negley DL; Schmaljohn A; Aman MJ; Bavari S
Vaccine; 2005 Apr; 23(23):3033-42. PubMed ID: 15811650
[TBL] [Abstract][Full Text] [Related]
26. Virus inoculation and treatment regimens for evaluating anti-filovirus monoclonal antibody efficacy
Banadyga L; Schiffman Z; He S; Qiu X
Biosaf Health; 2019 Jun; 1(1):6-13. PubMed ID: 32835206
[TBL] [Abstract][Full Text] [Related]
27. Correlates of immunity to filovirus infection.
Bradfute SB; Bavari S
Viruses; 2011 Jul; 3(7):982-1000. PubMed ID: 21994766
[TBL] [Abstract][Full Text] [Related]
28. Seroepidemiological Prevalence of Multiple Species of Filoviruses in Fruit Bats (Eidolon helvum) Migrating in Africa.
Ogawa H; Miyamoto H; Nakayama E; Yoshida R; Nakamura I; Sawa H; Ishii A; Thomas Y; Nakagawa E; Matsuno K; Kajihara M; Maruyama J; Nao N; Muramatsu M; Kuroda M; Simulundu E; Changula K; Hang'ombe B; Namangala B; Nambota A; Katampi J; Igarashi M; Ito K; Feldmann H; Sugimoto C; Moonga L; Mweene A; Takada A
J Infect Dis; 2015 Oct; 212 Suppl 2():S101-8. PubMed ID: 25786916
[TBL] [Abstract][Full Text] [Related]
29. Rapid molecular strategy for filovirus detection and characterization.
Zhai J; Palacios G; Towner JS; Jabado O; Kapoor V; Venter M; Grolla A; Briese T; Paweska J; Swanepoel R; Feldmann H; Nichol ST; Lipkin WI
J Clin Microbiol; 2007 Jan; 45(1):224-6. PubMed ID: 17079496
[TBL] [Abstract][Full Text] [Related]
30. Broad and Temperature Independent Replication Potential of Filoviruses on Cells Derived From Old and New World Bat Species.
Miller MR; McMinn RJ; Misra V; Schountz T; Müller MA; Kurth A; Munster VJ
J Infect Dis; 2016 Oct; 214(suppl 3):S297-S302. PubMed ID: 27354372
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of RealStar Reverse Transcription-Polymerase Chain Reaction Kits for Filovirus Detection in the Laboratory and Field.
Rieger T; Kerber R; El Halas H; Pallasch E; Duraffour S; Günther S; Ölschläger S
J Infect Dis; 2016 Oct; 214(suppl 3):S243-S249. PubMed ID: 27549586
[TBL] [Abstract][Full Text] [Related]
32. Filoviruses Infect Rhesus Macaque Synoviocytes in Vivo and Primary Human Synoviocytes in Vitro.
Cooper TK; Logue J; Liu DX; Perry DL; Hart RJ; Hischak AMW; Bernbaum JG; Gerhardt DM; Rojas O; Bohannon JK; Hagen KR; Johnson RF; Crozier I; Jahrling PB; Hensley LE; Bennett RS
Am J Pathol; 2020 Sep; 190(9):1867-1880. PubMed ID: 32479821
[TBL] [Abstract][Full Text] [Related]
33. Permissivity of Dipeptidyl Peptidase 4 Orthologs to Middle East Respiratory Syndrome Coronavirus Is Governed by Glycosylation and Other Complex Determinants.
Peck KM; Scobey T; Swanstrom J; Jensen KL; Burch CL; Baric RS; Heise MT
J Virol; 2017 Oct; 91(19):. PubMed ID: 28747502
[TBL] [Abstract][Full Text] [Related]
34. Treatment-focused Ebola trials, supportive care and future of filovirus care.
Keshtkar-Jahromi M; Martins KAO; Cardile AP; Reisler RB; Christopher GW; Bavari S
Expert Rev Anti Infect Ther; 2018 Jan; 16(1):67-76. PubMed ID: 29210303
[TBL] [Abstract][Full Text] [Related]
35. Modeling Ebola Virus Transmission Using Ferrets.
de La Vega MA; Soule G; Tran KN; Tierney K; He S; Wong G; Qiu X; Kobinger GP
mSphere; 2018 Oct; 3(5):. PubMed ID: 30381349
[TBL] [Abstract][Full Text] [Related]
36. Therapeutics for filovirus infection: traditional approaches and progress towards in silico drug design.
Shurtleff AC; Nguyen TL; Kingery DA; Bavari S
Expert Opin Drug Discov; 2012 Oct; 7(10):935-54. PubMed ID: 22873527
[TBL] [Abstract][Full Text] [Related]
37. Experimental models for study of common respiratory viruses.
Clyde WA
Environ Health Perspect; 1980 Apr; 35():107-12. PubMed ID: 6250807
[TBL] [Abstract][Full Text] [Related]
38. [Filovirus infection: pathogenesis and host specificity].
Takada A
Tanpakushitsu Kakusan Koso; 2007 Aug; 52(10 Suppl):1242-7. PubMed ID: 17824247
[No Abstract] [Full Text] [Related]
39. Testing Experimental Therapies in a Guinea Pig Model for Hemorrhagic Fever.
Wong G; Bi Y; Kobinger G; Gao GF; Qiu X
Methods Mol Biol; 2018; 1604():269-278. PubMed ID: 28986842
[TBL] [Abstract][Full Text] [Related]
40. Post-exposure therapy of filovirus infections.
Wong G; Qiu X; Olinger GG; Kobinger GP
Trends Microbiol; 2014 Aug; 22(8):456-63. PubMed ID: 24794572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
